1 July 2020
Deals | France | International Capital Markets
Gide advised bioMérieux in connection with its syndicated issuance structured in two tranches for a total amount of EUR 200 million (EUR 145 million 1.50 per cent. Notes due 29 June 2027 and EUR 55 million 1.902 per cent. Notes due 29 June 2030). The notes are admitted to trading on Euronext Access (Paris).
Gide’s team was led by partner Hubert du Vignaux, assisted by associates Louis Ravaud and Lou Recht.
The bank syndicate, composed of BNP Paribas and Crédit Agricole Corporate and Investment Bank, was advised by Allen & Overy.